Blog
RSS FeedPosted by Michael Wonder on 18 Sep 2024
The ICER developing special report for submission to CMS as part of public comment process on Medicare drug price negotiations
18 September 2024 - Report to reflect legislative specifications in the Inflation Reduction Act and subsequent CMS guidance regarding price ...
Posted by Michael Wonder on 02 Oct 2023
ICER publishes special report on Eliquis and Xarelto submitted to CMS as part of public comment process on Medicare drug price negotiations
2 October 2023 - Report tailored to reflect legislative specifications in the Inflation Reduction Act and subsequent CMS guidance regarding ...
Posted by Michael Wonder on 08 Jun 2023
Congress’ misguided plan to ban QALYs
8 June 2023 - Paying for health care is a challenge for many Americans, but the House of Representatives is on ...
Posted by Michael Wonder on 14 Apr 2023
Throwing the baby out with the bath water: Congress considers banning the QALY
3 April 2023 - In late March, the House Committee on Energy and Commerce advanced H.R. 485 - Protecting Health ...
Posted by Michael Wonder on 10 Feb 2022
A new way to contain unaffordable medication costs - exercising the Government’s existing rights
9 February 2022 - Existing laws could be used to help make many drugs more affordable. ...
Posted by Michael Wonder on 15 Feb 2021
Drug prices by committee: one way Biden could lower costs
11 February 2021 - Many countries use independent review boards to balance innovation and profit. ...
Posted by Michael Wonder on 20 Oct 2020
Biden looks to Germany for answers on how to tackle high U.S. drug prices
20 October 2020 - With the U.S. election just two weeks away, Democratic presidential nominee Joe Biden is offering clues ...
Posted by Michael Wonder on 12 Feb 2020
ICER methods could be illegal in US, claims US think tank
11 February 2020 - The method used by the US Institute for Clinical and Economic Review (ICER) to gauge whether ...